MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).

Jan 30, 2025 · Mircera (methoxy polyethylene glycol-epoetin beta) is commonly used to treat anemia due to chronic kidney disease. Mircera may also be used for other conditions as determined by your …

What is Mircera? Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called erythropoietin to …

Jun 5, 2024 · Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more …

What is MIRCERA ®? MIRCERA ® is a Continuous Erythropoetin Receptor Activator (C.E.R.A.) indicated for: the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in …

Oct 17, 2024 · Mircera (Methoxy Polyethylene glycol-epoetin beta) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison …

Jun 26, 2024 · Mircera is a man-made form of a protein normally produced by the kidneys that helps your body produce red blood cells. When your body does not make enough of this protein because …

Methoxy polyethylene glycol-epoetin beta, sold under the brand name Mircera, is a long-acting erythropoietin receptor activator (CERA) used for the treatment of anaemia associated with chronic …

Indicated for treatment of anemia associated with chronic kidney disease (CKD) in adults on dialysis or not on dialysis. Individualize dose and use lowest dose sufficient to reduce need for RBC...

Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more deaths among...